Luo Kuntian, Deng Min, Li Yunhui, Wu Chenming, Xu Ziwen, Yuan Jian, Lou Zhenkun
Research Center for Translational Medicine, East Hospital, Tongji University School of Medicine, No. 150 Jimo Road, Shanghai 200120, China Key Laboratory of Arrhythmia, Ministry of Education, East Hospital, Tongji University School of Medicine, No. 150 Jimo Road, Shanghai 200120, China
Division of Oncology Research, Department of Oncology, Mayo Clinic, 200 1st St. SW, Rochester, MN 55905, USA.
Nucleic Acids Res. 2015 Jun 23;43(11):5465-75. doi: 10.1093/nar/gkv434. Epub 2015 May 6.
There are the two major pathways responsible for the repair of DNA double-strand breaks (DSBs): non-homologous end-joining (NHEJ) and homologous recombination (HR). NHEJ operates throughout the cell-cycle, while HR is primarily active in the S/G2 phases suggesting that there are cell cycle-specific mechanisms that regulate the balance between NHEJ and HR. Here we reported that CDK2 could phosphorylate RNF4 on T26 and T112 and enhance RNF4 E3 ligase activity, which is important for MDC1 degradation and proper HR repair during S phase. Mutation of the RNF4 phosphorylation sites results in MDC1 stabilization, which in turn compromised HR during S-phase. These results suggest that in addition to drive cell cycle progression, CDK also targets RNF4, which is involved in the regulatory network of DSBs repair.
有两条主要途径负责DNA双链断裂(DSB)的修复:非同源末端连接(NHEJ)和同源重组(HR)。NHEJ在整个细胞周期中发挥作用,而HR主要在S/G2期活跃,这表明存在细胞周期特异性机制来调节NHEJ和HR之间的平衡。在此,我们报道CDK2可在T26和T112位点磷酸化RNF4并增强RNF4 E3连接酶活性,这对于S期MDC1的降解和适当的HR修复很重要。RNF4磷酸化位点的突变导致MDC1稳定,进而损害S期的HR。这些结果表明,CDK除了驱动细胞周期进程外,还靶向参与DSB修复调控网络的RNF4。